Propofol and bupivacaine in breast cancer cell function in vitro - Role of the NET1 gene

Anticancer Research

Volumn 34, Issue 3, 2014, Pages 1321-1331

  Ecimovic, Patricija ^a   Murray, David ^b   Doran, Peter ^b   Buggy, Donal J ^a,b,c  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer cells; Bupivacaine; Cell migration; MCF7; MDA MB 231; NET1 gene; Propofol

Indexed keywords

BUPIVACAINE; ESTROGEN RECEPTOR; LYSOPHOSPHATIDIC ACID; NEUROEPITHELIAL CELL TRANSFORMING 1 PROTEIN; PROPOFOL; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; INTRAVENOUS ANESTHETIC AGENT; LOCAL ANESTHETIC AGENT; MESSENGER RNA; NET1 PROTEIN, HUMAN; ONCOPROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION ASSAY; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; REAL TIME POLYMERASE CHAIN REACTION; APOPTOSIS; BREAST CANCER CELLS; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; DRUG ANTAGONISM; FEMALE; GENETICS; MCF7; MDA-MB-231; METABOLISM; NET1 GENE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

BREAST CANCER CELLS; BUPIVACAINE; CELL MIGRATION; MCF7; MDA-MB-231; NET1 GENE; PROPOFOL;

ANESTHETICS, INTRAVENOUS; ANESTHETICS, LOCAL; APOPTOSIS; BREAST NEOPLASMS; BUPIVACAINE; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; ONCOGENE PROTEINS; PROPOFOL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84899668457     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Heaney A and Buggy DJ: Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth 109(Suppl 1): i17-i28, 2012.
2. Snyder GL and Greenberg S: Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 105: 106-115, 2010.
3. Kavanagh T and Buggy DJ: Can anaesthetic technique affect postoperative outcome? Curr Opin Anaesthesiol 25(2): 185-198, 2012.
4. Conrick-Martin I and Buggy DJ: The effects of anesthetic and analgesic techniques on immune function. J Clin Anesth. S0952-8180(13)00084-6, 2013.
5. Colvin LA, Fallon MT and Buggy DJ: Cancer biology, analgesics, and anaesthetics: Is there a link? Br J Anaesth 109(2): 140-143, 2012.
6. Ren XF, Li WZ, Meng FY and Lin CF: Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia 65: 478-482, 2010.
7. Kambara T, Inada T, Kubo K and Shingu K: Propofol suppresses prostaglandin E(2) production in human peripheral monocytes. Immunopharmacol Immunotoxicol 31: 117-126, 2009.
8. Piegeler T, Votta-Velis EG, Liu G, Place AT, Schwartz DE, Beck-Schimmer B, Minshall RD and Borgeat A: Antimetastatic potential of amide-linked local anesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory SRC signaling independent of sodium channel blockade. Anesthesiology 117(3): 548-559, 2012.
9. House CD, Vaske CJ, Schwartz AM, Obias V, Frank B, Luu T, Sarvazyan N, Irby R, Strausberg RL, Hales TG, Stuart JM and Lee NH: Voltage-gated Na + channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res 1;70(17): 6957-6967, 2010.
10. Abba MC, Hu Y, Sun H, Drake JA, Gaddis S, Baggerly K, Sahin A and Aldaz CM: Gene expression signature of estrogen receptor α status in breast cancer. BMC Genomics 6: 1-13, 2005.
11. Bortsov AV, Millikan RC, Belfer I, Boortz-Marx RL, Arora H and McLean SA: μ-Opioid receptor gene A118G polymorphism predicts survival in patie nts with breast cancer. Anesthesiology 116(4): 896-902, 2012.
12. Gilcrease MZ, Kilpatrick SK, Woodward WA, Zhou X, Nicolas MM, Corley LJ, Fuller GN, Tucker SL, Diaz LK, Buchholz TA and Frost JA: Coexpression of α6β4 integrin and guanine nucleotide exchange factor NET1 identifies node-positive breast cancer patients at high risk for distant metastasis. Cancer Epidemiol Biomarkers Prev 18: 80-86, 2009.
13. Ecimovic P, Murray D, Doran P, McDonald J, Lambert DG and Buggy DJ: Direct effect of morphine on breast cancer cell function in vitro: Role of the NET1 gene. Br J Anaesth 107(6): 916-923, 2011
14. Gepts E, Camu F, Cockshot ID and Douglas EJ: Disposition of propofol administered as constant rate intravenous infusion in humans. Anesth Analg 66: 1256-1263, 1987.
15. Mills GB and Moolenaar WH: The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3: 582-591, 2003.
16. Evers EE, Zondag GC, Malliri A, Price LS, ten Klooster JP, van der Kammen RA and Collard JG: Rho family proteins in cell adhesion and cell migration. Eur J Cancer 36: 1269-1274, 2000.
17. Murray D, Horgan G, Macmathuna P and Doran P: NET1- mediated RhoA activation facilitates lysophosphatidic acidinduced cell migration and invasion in gastric cancer. Br J Cancer 99: 1322-1329, 2008.
18. Wu GJ, Tai YT, Chen TL, Lin LL, Ueng YF and Chen RM: Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity, thus reducing cellular ATP biosynthesis and migration of macrophages. Ann NY Acad Sci 1042: 168-176, 2005.
19. Hofbauer R, Frass M, Salfinger H, Moser D, Hornykewycz S, Gmeiner B and Kapiotis S: Propofol reduces the migration of human leucocytes through endothelial cell monolayers. Crit Care Med 27: 1843-1847, 1999.
20. Chen RM, Wu GJ, Chang HC, Chen JT, Chen TF, Lin YL and Chen TL: 2,6-Diisopropylphenol protects osteoblasts from oxidative stress-induced apoptosis through suppression of caspase-3 activation. Ann NY Acad Sci 1042: 448-459, 2005.
21. Cheng TH, Leung YM, Cheung CW, Chen CH, Chen YL and Wong KL: Propofol depresses angiotensin II-induced cell proliferation in rat cardiac fibroblasts. Anesthesiology 112: 108-118, 2010.
22. Garib V, Lang K, Niggemann B, Zanker KS, Brandt L, Dittmar T. Garib V, Niggemann B, Zanker KS, Brandt L and Kubens BS: Influence of non-volatile anesthetics on the migration behavior of the human breast cancer cell line MDA-MB-468. Acta Anaesthesiol Scand 46: 836-844, 2002.
23. Oscarsson A, Juhas M, Sjolander A and Eintrei C: The effect of propofol on actin, ERK-1/2 and GABAA receptor content in neurones. Acta Anaesthesiol Scand 51: 1184-1189, 2007.
24. Oscarsson A, Massoumi R, Sjolander A and Eintrei C: Reorganization of actin in neurons after propofol exposure. Acta Anaesthesiol Scand 45: 1215-1220, 2001.
25. Mammoto T, Mukai M, Mammoto A, Yamanaka Y, Hayashi Y, Mashimo T, Kishi Y and Nakamura H: Intravenous anesthetic propofol inhibits invasion of cancer cells. Cancer Lett 184: 165-170, 2002.
26. Clark EA, Golub TR, Lander ES and Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532-535, 2000.
27. Leyden J, Murray D, Moss A, Arumuguma M, Doyle E, McEntee G, O'Keane C and Doran P: Net1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer 94: 1204-1212, 2006.
28. Rossman KL, Der CJ and Sondek J: GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6: 167-180, 2005
29. Shen X, Li J, Hu PP, Waddell D, Zhang J and Wang X: The activity of Guanine exchange factor NET1 is essential for transforming growth factor-β-mediated stress fiber formation. J Biol Chem 276: 15363-15368, 2001.
30. Nakazato K, Yoshida Y, Takemori K, Kobayashi K and Sakamoto A: Expressions of genes encoding drug-metabolizing enzymes are altered after sevoflurane, isoflurane, propofol or dexmedetomidine anesthesia. Biomedical Research 30: 17-24, 2009.
31. Kotani N, Hashimoto H, Sessler DI, Yasuda T, Ebina T, Muraoka M and Matsuki A: Expression of genes for proinflammatory cytokines in alveolar macrophages during propofol and isoflurane anesthesia. Anesth Analg 89: 1250-1256, 1999.
32. Kotani Y, Shimazawa M, Yoshimura S, Iwama T and Hara H: The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther 14: 95-106, 2008.
33. Harvey KA, Xu Z, Whitley P, Davisson VJ and Siddiqui RA: Characterization of anticancer properties of 2,6- diisopropylphenol-docosahexaenoate and analogues in breast cancer cells. Bioorg Med Chem 18(5): 1866-1874, 2010.
34. O'Riain SC, Buggy DJ, Kerin MJ, Watson RW and Moriarty DC: Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg 100(1): 244-249, 2005.
35. Lirk P, Berger R, Hollmann MW and Fiegl H: Lidocaine timeand dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro. Br J Anaesth 109(2): 200-207, 2012.
36. Lucchinetti E, Awad AE, Rahman M, Feng J, Lou PH, Zhang L, Ionescu L, Lemieux H, Thebaud B and Zaugg M: Antiproliferative effects of local anesthetics on mesenchymal stem cells: potential implications for tumor spreading and wound healing. Anesthesiology 116(4): 841-856, 2012.